CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Generic: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
E. Fougera & Co. a division of Fougera PharmaceuticalsManufacturer
TOPICALRoute
CLOTRIMAZOLEActive Substance
2001-06-05Original Approval
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE is FDA application ANDA075502, sponsored by FOUGERA PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2019-08-07
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark PharmTemperature Abuse: Complaints received of liquidy texture.
Class III2022-02-25
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro PharmaceuticaFailed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropio
Top Reported Reactions
1
CHRONIC KIDNEY DISEASE
55 reports
2
FATIGUE
37 reports
3
RENAL FAILURE
34 reports
4
ACUTE KIDNEY INJURY
24 reports
5
DRUG INEFFECTIVE
24 reports
6
NAUSEA
24 reports
7
DYSPNOEA
21 reports
8
PAIN
20 reports
9
RASH
20 reports
10
DIZZINESS
19 reports